18-6980524-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005559.4(LAMA1):​c.6004A>G​(p.Lys2002Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.714 in 1,564,944 control chromosomes in the GnomAD database, including 401,658 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.68 ( 36221 hom., cov: 33)
Exomes 𝑓: 0.72 ( 365437 hom. )

Consequence

LAMA1
NM_005559.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.50

Publications

38 publications found
Variant links:
Genes affected
LAMA1 (HGNC:6481): (laminin subunit alpha 1) This gene encodes one of the alpha 1 subunits of laminin. The laminins are a family of extracellular matrix glycoproteins that have a heterotrimeric structure consisting of an alpha, beta and gamma chain. These proteins make up a major component of the basement membrane and have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Mutations in this gene may be associated with Poretti-Boltshauser syndrome. [provided by RefSeq, Sep 2014]
LAMA1 Gene-Disease associations (from GenCC):
  • ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.886197E-7).
BP6
Variant 18-6980524-T-C is Benign according to our data. Variant chr18-6980524-T-C is described in ClinVar as Benign. ClinVar VariationId is 1168731.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.813 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMA1NM_005559.4 linkc.6004A>G p.Lys2002Glu missense_variant Exon 42 of 63 ENST00000389658.4 NP_005550.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMA1ENST00000389658.4 linkc.6004A>G p.Lys2002Glu missense_variant Exon 42 of 63 1 NM_005559.4 ENSP00000374309.3
LAMA1ENST00000579014.5 linkn.7019A>G non_coding_transcript_exon_variant Exon 41 of 62 2

Frequencies

GnomAD3 genomes
AF:
0.685
AC:
104126
AN:
151996
Hom.:
36196
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.563
Gnomad AMI
AF:
0.591
Gnomad AMR
AF:
0.749
Gnomad ASJ
AF:
0.722
Gnomad EAS
AF:
0.833
Gnomad SAS
AF:
0.733
Gnomad FIN
AF:
0.745
Gnomad MID
AF:
0.687
Gnomad NFE
AF:
0.719
Gnomad OTH
AF:
0.710
GnomAD2 exomes
AF:
0.735
AC:
184537
AN:
251108
AF XY:
0.733
show subpopulations
Gnomad AFR exome
AF:
0.558
Gnomad AMR exome
AF:
0.833
Gnomad ASJ exome
AF:
0.730
Gnomad EAS exome
AF:
0.827
Gnomad FIN exome
AF:
0.748
Gnomad NFE exome
AF:
0.715
Gnomad OTH exome
AF:
0.735
GnomAD4 exome
AF:
0.718
AC:
1013922
AN:
1412830
Hom.:
365437
Cov.:
25
AF XY:
0.718
AC XY:
507326
AN XY:
706436
show subpopulations
African (AFR)
AF:
0.559
AC:
18196
AN:
32544
American (AMR)
AF:
0.827
AC:
36929
AN:
44652
Ashkenazi Jewish (ASJ)
AF:
0.726
AC:
18770
AN:
25838
East Asian (EAS)
AF:
0.824
AC:
32508
AN:
39448
South Asian (SAS)
AF:
0.726
AC:
61848
AN:
85220
European-Finnish (FIN)
AF:
0.745
AC:
39698
AN:
53280
Middle Eastern (MID)
AF:
0.697
AC:
3955
AN:
5674
European-Non Finnish (NFE)
AF:
0.712
AC:
759811
AN:
1067458
Other (OTH)
AF:
0.719
AC:
42207
AN:
58716
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
13443
26885
40328
53770
67213
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
18730
37460
56190
74920
93650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.685
AC:
104198
AN:
152114
Hom.:
36221
Cov.:
33
AF XY:
0.690
AC XY:
51300
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.563
AC:
23358
AN:
41456
American (AMR)
AF:
0.750
AC:
11464
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.722
AC:
2504
AN:
3470
East Asian (EAS)
AF:
0.834
AC:
4316
AN:
5176
South Asian (SAS)
AF:
0.732
AC:
3535
AN:
4828
European-Finnish (FIN)
AF:
0.745
AC:
7881
AN:
10580
Middle Eastern (MID)
AF:
0.680
AC:
200
AN:
294
European-Non Finnish (NFE)
AF:
0.719
AC:
48906
AN:
67998
Other (OTH)
AF:
0.708
AC:
1495
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1649
3298
4947
6596
8245
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
822
1644
2466
3288
4110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.710
Hom.:
190286
Bravo
AF:
0.682
TwinsUK
AF:
0.728
AC:
2700
ALSPAC
AF:
0.697
AC:
2688
ESP6500AA
AF:
0.553
AC:
2436
ESP6500EA
AF:
0.715
AC:
6146
ExAC
AF:
0.727
AC:
88298
Asia WGS
AF:
0.788
AC:
2738
AN:
3476
EpiCase
AF:
0.712
EpiControl
AF:
0.719

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 08, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Ataxia - intellectual disability - oculomotor apraxia - cerebellar cysts syndrome Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.79
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
15
DANN
Benign
0.97
DEOGEN2
Benign
0.012
T
Eigen
Benign
-0.99
Eigen_PC
Benign
-0.74
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.14
T
MetaRNN
Benign
6.9e-7
T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
-1.7
N
PhyloP100
1.5
PrimateAI
Benign
0.21
T
PROVEAN
Benign
0.97
N
REVEL
Benign
0.034
Sift
Benign
0.43
T
Sift4G
Benign
0.32
T
Polyphen
0.0
B
Vest4
0.0080
MPC
0.15
ClinPred
0.0046
T
GERP RS
3.3
Varity_R
0.039
gMVP
0.082
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs607230; hg19: chr18-6980523; COSMIC: COSV107500176; API